Wan Rosalina, W R <br/><br/>
Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Apr 2012 
 - 237-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2710.2011.01272.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Case-Control Studies<br/>Child<br/>Child, Preschool<br/>Ethnicity--genetics<br/>Female<br/>Genotype<br/>Humans<br/>Infant<br/>Malaysia<br/>Male<br/>Mercaptopurine--adverse effects<br/>Methyltransferases--genetics<br/>Polymorphism, Genetic<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Pyrophosphatases--genetics<br/>Young Adult<br/>Inosine Triphosphatase